Tepotinib HCl |
Tablet |
II (Paddle) |
50 |
Acetate buffer, pH 4.5 + 1 mM NaCl + 0.1% polysorbate 80 |
900 |
5, 15, 20 and 35 |
2023/03/30 |
Terazosin HCl |
Tablet |
|
|
Develop a dissolution method |
|
|
2023/09/15 |
Terazosin HCl |
Capsule |
|
|
Develop a dissolution method |
|
|
2023/09/15 |
Terbinafine HCl |
Tablet |
II (Paddle) |
50 |
Citrate Buffer, pH 3.0 adjusted with HCl |
500 |
10, 20, 30 and 45 |
2004/02/20 |
Terconazole |
Suppository (Vaginal) |
I (with Palmieri type basket) |
100 |
0.12 N HCl with 1% SLS |
900 |
15, 30, 45, 60, 90, 120 and 150 |
2009/10/08 |
Teriflunomide |
Tablet |
II (Paddle) |
50 |
0.05 M Phosphate Buffer, pH 6.8 |
1000 |
5, 10, 15, 20, 30 and 45 |
2014/05/15 |
Testosterone |
Film, Transdermal (Extended Release) |
V (Paddle over disk). Paddle 25 mm above the film on the disk. |
50 |
0.1 M sodium chloride containing 2.5% (v/v) of Tween 40 at 32 ± 0.5°C. Delivery surface faces upwards towards the media. |
900 |
1, 3, 5, 7, 11, 16, 20 and 24 hours |
2011/06/30 |
Testosterone |
Buccal Tablet (Extended Release) |
|
|
Develop a dissolution method |
|
|
2023/09/15 |
Testosterone |
Pellet Implant |
|
|
Develop a dissolution method |
|
|
2008/11/25 |
Testosterone Undecanoate |
Capsule |
II (Paddle) |
75 |
0.01 N HCl with 0.5% Triton X 100 |
900 |
5, 10, 15, 30, 45 and 60 |
2024/02/05 |
Testosterone Undecanoate |
Capsule |
II (Paddle) |
75 |
Phosphate buffer pH 6.8 with 1.0% Triton X-100 |
900 |
10, 15, 20, 30 and 45 |
2021/08/19 |
Tetrabenazine |
Tablet |
II (Paddle) |
50 |
0.1 N HCl |
900 |
5, 10, 15, 30 and 45 |
2011/09/01 |
Tetracycline HCl |
Tablet |
|
|
Refer to FDA's Dissolution Guidance, 2018 |
|
|
2020/07/02 |
Tetracycline HCl |
Capsule |
|
|
Refer to FDA's Dissolution Guidance, 2018 |
|
|
2020/07/02 |
Thalidomide |
Capsule |
II (Paddle) |
100 |
1.5% (w/v) SLS (pH 3.0, adj w/ HCl) |
900 |
10, 20, 30, 60 and 90 |
2006/03/04 |
Theophylline |
Capsule (Extended Release) |
|
|
Refer to USP |
900 |
|
2008/10/06 |
Theophylline (100 mg and 200 mg) |
Tablet (Extended Release) |
II (Paddle) |
50 |
SGF without Enzyme, pH 1.2 during 1st hour. Phosphate Buffer at pH 7.5 from end of hour 1 through the duration of testing |
900 |
1, 4, 8, 12 hours |
2008/10/06 |
Theophylline (300 mg and 450 mg) |
Tablet (Extended Release) |
II (Paddle) |
50 |
SGF without Enzyme, pH 1.2 during 1st hour. Phosphate Buffer at pH 7.5 from end of hour 1 through the duration of testing |
900 |
1, 4, 8, 12 hours |
2008/10/06 |
Theophylline (600 mg and 400 mg) |
Tablet (Extended Release) |
I (Basket) |
100 |
SGF without enzyme, pH 1.2 during 1st hour. SIF without enzyme from end of hour 1 through the duration of the testing |
900 |
1, 2, 4, 8, 12 and 24 hours |
2008/10/06 |
Thioguanine |
Tablet |
|
|
Develop a dissolution method |
|
|
2024/01/03 |